Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus vs Corticosteroids in Active Thyroid Eye Disease
NCT04936854Phase 2Recruiting
- Sponsor
- Haukeland University Hospital
- Start
- Jan 2023
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in thyroid eye disease (TED), sponsored by Haukeland University Hospital. Started Jan 2023; status: recruiting.
02
Drugs
sirolimus
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT04936854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04936854.